AR229778A1 - Metodo para estabilizar interferon b - Google Patents

Metodo para estabilizar interferon b

Info

Publication number
AR229778A1
AR229778A1 AR292391A AR29239183A AR229778A1 AR 229778 A1 AR229778 A1 AR 229778A1 AR 292391 A AR292391 A AR 292391A AR 29239183 A AR29239183 A AR 29239183A AR 229778 A1 AR229778 A1 AR 229778A1
Authority
AR
Argentina
Prior art keywords
stabilize interferon
interferon
stabilize
Prior art date
Application number
AR292391A
Other languages
English (en)
Original Assignee
Inter Yeda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL65277A external-priority patent/IL65277A/xx
Application filed by Inter Yeda Ltd filed Critical Inter Yeda Ltd
Application granted granted Critical
Publication of AR229778A1 publication Critical patent/AR229778A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AR292391A 1982-03-17 1983-03-15 Metodo para estabilizar interferon b AR229778A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL65277A IL65277A (en) 1982-03-17 1982-03-17 Stable interferon beta composition and a method of stabilizing interferon beta
BE897276 1983-07-13
BE0/211166A BE897276A (fr) 1982-03-17 1983-07-13 Compositions d'interferon b stales et procede de stabilisation l'interferon b

Publications (1)

Publication Number Publication Date
AR229778A1 true AR229778A1 (es) 1983-11-30

Family

ID=27158741

Family Applications (1)

Application Number Title Priority Date Filing Date
AR292391A AR229778A1 (es) 1982-03-17 1983-03-15 Metodo para estabilizar interferon b

Country Status (7)

Country Link
US (1) US4647454A (es)
EP (1) EP0089245A3 (es)
JP (1) JPS5910598A (es)
AR (1) AR229778A1 (es)
AU (1) AU1234383A (es)
BE (1) BE897276A (es)
CA (1) CA1209473A (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS61500790A (ja) * 1984-03-28 1986-04-24 シタス　コ−ポレイシヨン 微生物的に製造されたインターロイキン―２を含有する組成物
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
EP0284249A1 (en) * 1987-03-13 1988-09-28 Interferon Sciences, Inc. Lyophilized lymphokine composition
US4973478A (en) * 1987-07-20 1990-11-27 Allelix Biopharmaceuticals, Inc. Treating inflammation with hepatocyte stimulating factor interferon β2
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5104651A (en) * 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
IT1272252B (it) * 1994-05-16 1997-06-16 Applied Research Systems Formulazioni liquide di interferone beta
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
EP1426058A3 (de) 1997-09-23 2004-07-28 Dr. Rentschler Biotechnologie GmbH Flüssige Interferon-Beta Formulierungen
US6979442B1 (en) 1998-08-17 2005-12-27 Pfizer Inc. Stabilized protein compositions
RU2140285C1 (ru) * 1999-01-25 1999-10-27 Гапонюк Петр Яковлевич Противовирусное средство - капли в нос "гриппферон"
AU3070702A (en) * 2000-11-07 2002-05-21 Chiron Corp Stabilized inteferon compositions
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
SI21257A (sl) * 2002-07-17 2004-02-29 LEK farmacevtska dru�ba d.d. Stabilni farmacevtski pripravek, ki vsebuje eritropoietin
JP2006510589A (ja) * 2002-09-05 2006-03-30 ザ ジェネラル ホスピタル コーポレーション アシアロインターフェロンおよび肝臓癌の治療
JP2006508918A (ja) * 2002-09-05 2006-03-16 ザ ジェネラル ホスピタル コーポレーション 修飾されたアシアロインターフェロンおよびその使用
BRPI0606658B8 (pt) * 2005-01-12 2021-05-25 Biogen Idec Inc método para armazenar e distribuir interferon-beta, e dispositivo
MX2011005056A (es) * 2008-11-17 2011-05-31 Genentech Inc Metodo y formulacion para reducir la agregacion de una macromolecula bajo condiciones fisiologicas.
WO2014199373A1 (en) * 2013-06-09 2014-12-18 Efranat Ltd. Compositions comprising gc- macrophage activating factor and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526205A (en) * 1974-11-07 1978-09-27 Searle & Co Treatment of interferon-like material
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives

Also Published As

Publication number Publication date
EP0089245A3 (en) 1986-06-11
EP0089245A2 (en) 1983-09-21
BE897276A (fr) 1983-11-03
AU1234383A (en) 1983-09-22
US4647454A (en) 1987-03-03
JPS5910598A (ja) 1984-01-20
CA1209473A (en) 1986-08-12

Similar Documents

Publication Publication Date Title
AR229778A1 (es) Metodo para estabilizar interferon b
MX7035E (es) Procedimiento para preparar 3-isoxazolidinona
FI830486L (fi) Lipider i vattenhaltig fas
ES539884A0 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pi- rrolidinonas
ES275671Y (es) Ballesta
ES275672Y (es) Ballesta
FI830085L (fi) Med handtag foersedd baerare foer behaollare eller dylika
ES544119A0 (es) Procedimiento para preparar nuevos bencimidazoles
BR8305347A (pt) Processo aperfeicoado para produzir metano
FI823729L (fi) Hydrauliksystem foer en traktor eller liknande
DK319883A (da) Interferonpraeparat
ES525079A0 (es) Un metodo para preparar 2(1h)-piridinonas
BR8302433A (pt) Processo para produzir eteres alqui-ter-butilicos
ES532173A0 (es) Un metodo para producir interferon
ES518959A0 (es) Procedimiento para preparar fenilureas.
FI834886A0 (fi) Hydrocyklon med vattentroeskel i oeverstroemningskanalen
DK303684A (da) Luftfartoej
ES531586A0 (es) Procedimiento para preparar difenilazometinas
BR8306216A (pt) Processo para produzir para-nitrodifenilaminas
ES530132A0 (es) Metodo para realizar un conjunto de catodo
FI833786A0 (fi) Badkar foer badterapi eller havsbadterapi foersett med luftinjekteringsdon
ES533830A0 (es) Procedimiento para preparar difenilazometinas
ES272552Y (es) Nueva ballesta para somieres
ES524785A0 (es) Procedimiento para preparar hidroxi-3-triazoles-1,2,4
FI832060L (fi) Fendert eller stoetfaongare